Pluribus Labs’s Nikola Corporation Common Stock NKLA Stock Holding History

Pluribus Labs’s Portfolio NKLA Stock Details NKLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-732	Closed	-$217K	–	230
2021 Q4	$217K	Buy	+732	New	+$244K	0.23%	200

Other funds holding NKLA

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pluribus Labs's NKLA Position: Q1 2022 in Review

Pluribus Labs sold out of Nikola Corporation Common Stock (NKLA) in Q1 2022, closing a stake of 732 shares — an estimated $217K sold.

Pluribus Labs first reported a position in NKLA in Q4 2021 and held it in 1 quarter. The position peaked at $217K in Q4 2021. 268 funds tracked by Wall St. Rank hold NKLA as of Q1 2022.

Pluribus Labs reported no remaining Nikola Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 732 Nikola Corporation Common Stock shares in Q1 2022, an estimated $217K.
Pluribus Labs first reported a position in Nikola Corporation Common Stock in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Nikola Corporation Common Stock position peaked at $217K in Q4 2021.
268 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.